Clinical Trials Browser

Phase 2 × INDUSTRY × Advanced Malignancy × Clear all

NCT04216082 2020-01-02

A Study of Anlotinib in Subjects With Advanced Malignancy

Phase 2 Completed

Advanced Malignancy